RA Capital Nexus Fund II, Director: Climb Bio CLYM Buy · Filed 24/07/01

Trade details

Type: Insider buy
Amount: $45,884,816.64
Shares · price: 11,949,171 sh · $3.84 a share
Held after: 23,521,757 sh
Stock: Climb Bio CLYM
Person: RA Capital Nexus Fund IIDirector
Trade date: 24/06/27
Filed: 24/07/01
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 7 insiders
Holding change: +103.3%

Climb Bio trades, last 26 weeks

What else happened in Climb Bio around then

Filed or reported within 30 days of the trade day · 24/05/28~24/07/27

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06